Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Blood tests Stories

2013-09-04 08:31:37

SAN DIEGO, Sept. 4, 2013 /PRNewswire/ -- Elcelyx Therapeutics announced today that NewMet(TM), the delayed-release formulation of generic metformin for the treatment of patients with Type 2 diabetes, met its primary study endpoint with statistically significant reductions in fasting plasma glucose at four weeks of treatment compared to placebo. The results from the randomized, 240-patient, multicenter U.S. Phase 2b trial confirm previous studies that showed NewMet reduced...

2013-08-28 08:27:28

Primary investigator presents results at the World Federation of Societies of Intensive and Critical Care Medicine (WFSICCM) Congress OXFORD, England, August 28, 2013 /PRNewswire/ -- GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, today announced that a study demonstrating the effectiveness of its technology in continuously measuring blood glucose levels in post-surgical cardiac surgery patients will be presented at the World...

2013-08-19 08:27:55

SANTA ROSA, Calif., Aug. 19, 2013 /PRNewswire/ --A groundbreaking peer reviewed case report by Dr. Isaac Eliaz, M.D. of Amitabha Medical Clinic, demonstrates for the first time the clinical use of novel biomarker galectin-3 to assess cancer progression and inflammation. The case study titled, "The Role of Galectin-3 as a Marker of Cancer and Inflammation in a Stage IV Ovarian Cancer Patient with Underlying Pro-Inflammatory Comorbidities," was published in the July 2013 issue of Case...

2013-08-08 09:26:53

University of Washington-Group Health study in New England Journal of Medicine A joint Group Health–University of Washington (UW) study in the New England Journal of Medicine has found that higher blood sugar levels are associated with higher dementia risk, even among people who do not have diabetes. Blood sugar levels averaged over a five-year period were associated with rising risks for developing dementia, in this report about more than 2,000 Group Health patients...

2013-07-25 12:27:21

Only inpatient blood glucose monitoring system among leading hospital brands to use individually foil-wrapped test strips, helping reduce risk of test strip cross-contamination ABBOTT PARK, Ill., July 25, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System(TM), an advanced blood glucose monitoring system designed to address the key...

2013-07-19 23:02:03

Get a picture of how the body is functioning with live blood cell analysis at About Your Health. Columbia, SC (PRWEB) July 19, 2013 About Your Health, a non-medical clinic focused on health education while also offering health enhancing services in Columbia, South Carolina, is now offering live blood cell analysis on Mondays and Thursdays. Live blood cell analysis is a powerful tool to see how the body is functioning. By seeing a visual image of their blood cells, patients can understand...

2013-07-18 23:22:39

Healthy Directions, a leading source of natural health advice and doctor-formulated nutritional products, announces the launch of Berberine+ GlucoDefense™, a proprietary blend of three ingredients that support healthy blood sugar levels. Potomac, MD (PRWEB) July 18, 2013 Healthy Directions, LLC, today announced the launch of Berberine+ GlucoDefense™, a unique blood sugar supplement formulated by Julian Whitaker, MD, that safely and naturally supports normal blood glucose and...

2013-07-15 13:06:07

When Georgetown University neurologist R. Scott Turner, MD, PhD, began enrolling people with mild to moderate Alzheimer's disease into a nationwide study last year, he expected to find only a handful of participants with undiagnosed glucose intolerance, as all the patients were already under a doctor's care and those with known diabetes were excluded. But Turner says he was "shocked" by how many study participants were found to have pre-diabetes — a finding that is...

2013-07-12 08:23:55

Consensus Statement Validates LDL-P Measurement by Nuclear Magnetic Resonance (NMR) in Patients with Diabetes to Reduce Risk of Cardiovascular Disease RALEIGH, N.C., July 12, 2013 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized NMR diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced that the American Association of Clinical Endocrinologists (AACE) has endorsed...

2013-07-04 12:21:48

DUBLIN, July 4, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wrjhsx/coagulation) has announced the addition of the "Coagulation Diagnostic Testing Markets" [http://www.researchandmarkets.com/research/wrjhsx/coagulation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Coagulation testing, which encompasses both laboratory and point of care (POC) testing, will continue to be one of the...